par Hildebrand, Jerzy ;Sahmoud, Tarek;Mignolet, François ;Brucher, Jean Marie;Afra, D;EORTC Brain Tumour Group,
Référence Neurology, 44, 8, page (1479-1483)
Publication Publié, 1994-08
Référence Neurology, 44, 8, page (1479-1483)
Publication Publié, 1994-08
Article révisé par les pairs
Titre: |
|
Auteur: | Hildebrand, Jerzy; Sahmoud, Tarek; Mignolet, François; Brucher, Jean Marie; Afra, D; EORTC Brain Tumour Group, |
Informations sur la publication: | Neurology, 44, 8, page (1479-1483) |
Statut de publication: | Publié, 1994-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Brain Neoplasms -- drug therapy | |
Brain Neoplasms -- mortality | |
Carmustine -- administration & dosage | |
Chemotherapy, Adjuvant | |
Female | |
Glioma -- drug therapy | |
Glioma -- mortality | |
Humans | |
Male | |
Middle Aged | |
Mitolactol -- administration & dosage | |
Survival Analysis | |
Note générale: | Clinical Trial |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0028-3878 |
info:scp/0028107037 | |
info:pmid/8058153 |